Introduction
Erythema multiforme is usually diagnosed by combining the clinical appearance of the skin and mucosal lesions with the patient’s recent medical history and, when needed, selected laboratory or tissue tests. In many cases, the diagnosis is made primarily by visual recognition of a characteristic pattern: target-shaped lesions that appear suddenly, often on the hands, feet, arms, or legs, sometimes with involvement of the lips or other mucosal surfaces. Because erythema multiforme can resemble several other inflammatory or blistering disorders, accurate diagnosis matters. The management approach, the likely trigger, and the expected course differ from conditions such as Stevens-Johnson syndrome, urticaria, or autoimmune blistering disease. Identifying the correct condition also helps clinicians decide whether a medication should be stopped, whether an infection needs treatment, and whether the patient requires closer monitoring.
Recognizing Possible Signs of the Condition
The first clue is often the pattern of the rash rather than any single symptom. Erythema multiforme classically produces target lesions or “iris” lesions, which are round or oval spots with concentric zones of color. The center may look darker, dusky, or blistered, while the outer rings are red and inflamed. These lesions are often distributed symmetrically, especially on the extensor surfaces of the extremities. The rash may be mildly itchy, painful, or accompanied by burning or tenderness.
Clinicians also look for signs of mucosal involvement. In erythema multiforme major, the lips, mouth, eyes, or genital mucosa may become inflamed, eroded, or crusted. Oral involvement can make eating and drinking painful. Unlike some other skin conditions, erythema multiforme often has a relatively abrupt onset, with lesions evolving over a short period and then remaining fixed for days rather than appearing and disappearing within hours.
Suspicion rises when the eruption follows a known trigger. The most common trigger is infection, particularly herpes simplex virus. Less commonly, Mycoplasma pneumoniae or certain medications may precede the eruption. A recent cold sore outbreak, respiratory illness, or new drug exposure can provide important diagnostic context. The underlying biology is an immune-mediated reaction in which cytotoxic T cells respond to an antigenic trigger and damage keratinocytes, producing the distinctive target lesion pattern.
Medical History and Physical Examination
Diagnosis begins with a detailed history. Health professionals ask when the rash started, how rapidly it spread, whether lesions are painful or itchy, and whether the skin changes are fixed or transient. They also ask about fever, sore throat, cough, eye irritation, mouth pain, difficulty swallowing, and genital symptoms. These questions help determine whether the condition is limited to the skin or includes mucosal disease.
A key part of the history is identifying recent triggers. Clinicians ask about recurrent herpes outbreaks, recent upper respiratory symptoms, gastrointestinal symptoms, and any newly started medications, including antibiotics, anticonvulsants, nonsteroidal anti-inflammatory drugs, and over-the-counter products. Timing matters. A medication started shortly before the eruption may raise concern for a drug-related reaction, while repeated episodes after herpes infection point more strongly toward infection-associated erythema multiforme.
The physical examination focuses on lesion morphology, distribution, and the extent of involvement. The examiner notes whether lesions are classic target lesions or less typical “raised” target lesions. They assess whether lesions are present mainly on the extremities and whether the trunk is spared or only mildly involved, which is often the case in erythema multiforme. Mucosal surfaces are examined carefully for erosions, crusting, ulceration, or conjunctival redness. The presence of widespread skin pain, skin sloughing, or a positive Nikolsky sign suggests a different and potentially more severe disorder.
In some cases, the exam may also include evaluation for dehydration, fever, lymph node enlargement, or signs of secondary infection. The goal is not only to identify erythema multiforme, but also to assess severity and determine whether the patient needs supportive care, ophthalmology review, or hospital admission.
Diagnostic Tests Used for Erythema multiforme
There is no single blood test that confirms erythema multiforme. Instead, tests are chosen to support the clinical impression, identify an associated trigger, and exclude look-alike conditions. The most important “test” remains direct observation by an experienced clinician, but additional studies are often used when the presentation is atypical or severe.
Laboratory tests may include a complete blood count and basic metabolic panel if the patient is ill, has fever, cannot maintain hydration, or has extensive mucosal involvement. These tests do not diagnose erythema multiforme directly, but they help assess overall health, detect electrolyte disturbances, and identify complications. If an infectious trigger is suspected, clinicians may order testing directed at the likely cause. For example, herpes simplex testing can be considered in recurrent cases, and evaluation for Mycoplasma pneumoniae may be appropriate when respiratory symptoms are present. Serologic or molecular studies may help document a trigger, although they are not always necessary for diagnosis.
Functional tests are not typical for diagnosing erythema multiforme, but functional assessment can be clinically useful. Eye examination may be needed if the patient reports redness, pain, tearing, or blurred vision, because ocular mucosal involvement can occur and may threaten vision if severe. Swallowing or hydration status may also be assessed if oral lesions limit intake. These assessments do not confirm the diagnosis, but they influence urgency and treatment planning.
Imaging tests are not standard for erythema multiforme itself. They may be used only when another illness is suspected, such as pneumonia in a patient with cough and fever, or when a clinician is investigating a broader systemic process. In routine erythema multiforme, imaging does not play a primary diagnostic role.
Tissue examination, usually by skin biopsy, is the most useful confirmatory test when the diagnosis is uncertain. Biopsy findings can show interface dermatitis with damage at the dermal-epidermal junction, necrotic keratinocytes, and a lymphocytic infiltrate. These changes reflect the immune attack on keratinocytes that underlies the disease. A biopsy is especially helpful when the eruption is atypical, when bullae are present, or when clinicians need to distinguish erythema multiforme from Stevens-Johnson syndrome, fixed drug eruption, bullous pemphigoid, or other blistering disorders. Direct immunofluorescence may be performed in some cases to help exclude autoimmune blistering disease, though it is not usually diagnostic for erythema multiforme itself.
Interpreting Diagnostic Results
Doctors interpret the results in the context of the clinical picture. A typical presentation with classic target lesions, symmetric acral distribution, and a relevant trigger may be sufficient for a clinical diagnosis, even if laboratory tests are unremarkable. Normal bloodwork does not rule out erythema multiforme because the disorder is primarily a cutaneous immune reaction rather than a systemic metabolic illness.
When biopsy is obtained, the presence of interface dermatitis and necrotic keratinocytes supports erythema multiforme, especially if the lesion pattern matches the clinical description. However, pathology is interpreted cautiously because some overlap exists with related disorders. The pathologist and clinician must consider lesion age, biopsy site, and whether mucosal lesions are present. Early and later lesions can appear somewhat different under the microscope.
If testing identifies herpes simplex or another trigger, that finding strengthens the diagnosis by linking the eruption to a known cause. Still, the diagnosis remains clinical because the trigger alone does not explain the skin pattern. In recurrent disease, repeated episodes associated with the same trigger are particularly suggestive. If the patient has been taking a new medication and the rash timing fits a drug reaction, clinicians must carefully consider whether the condition is truly erythema multiforme or a different drug-induced mucocutaneous reaction.
When results are inconsistent with the expected pattern, clinicians reconsider the diagnosis. For example, widespread skin tenderness, extensive epidermal detachment, or rapidly progressive blistering would argue against typical erythema multiforme and toward a more serious alternative diagnosis. The interpretation process therefore depends on matching test findings with the lesion distribution, mucosal involvement, trigger history, and severity of illness.
Conditions That May Need to Be Distinguished
Several disorders can mimic erythema multiforme, and distinguishing them is a central part of diagnosis. One major concern is Stevens-Johnson syndrome and the related toxic epidermal necrolysis spectrum. These conditions usually produce more extensive skin pain, prominent mucosal involvement, and skin detachment. The lesions are less likely to be classic target lesions, and the clinical course is often more severe. Because management and prognosis differ substantially, clinicians are careful not to confuse these entities.
Fixed drug eruption can also resemble erythema multiforme, particularly when lesions recur in the same location after drug exposure. However, fixed drug eruption typically produces fewer lesions and often leaves the same site affected with each episode. Urticaria can look similar early on, but hives are transient and move around, whereas erythema multiforme lesions remain fixed and evolve more slowly. Bullous pemphigoid, pemphigus vulgaris, and other autoimmune blistering disorders may require biopsy and immunofluorescence studies to exclude them.
Infections can also produce overlapping rashes. Viral exanthems, hand-foot-and-mouth disease, and the mucocutaneous eruption linked to Mycoplasma infection may create diagnostic uncertainty. In children, clinicians also consider Kawasaki disease, urticaria multiforme, and other pediatric inflammatory syndromes. The differentiation depends on the age of the patient, the lesion shape, whether the mucosa is involved, and whether the lesions are fixed target lesions rather than diffuse or migratory erythema.
Factors That Influence Diagnosis
Several factors can shape how erythema multiforme is diagnosed. Severity is one of the most important. Mild cases with only a few skin lesions may be diagnosed clinically and observed, while severe mucosal disease or diagnostic uncertainty may prompt biopsy, specialty consultation, or closer follow-up. Extensive involvement of the eyes, mouth, or genitals changes both the urgency and the scope of evaluation.
Age also matters. Children and young adults commonly present with infection-associated eruptions, especially after herpes simplex infection, while medication-related causes may be more common in older adults depending on exposure patterns. Pediatric patients may not describe symptoms clearly, so caregivers’ observations become especially important.
Underlying medical conditions and medications can complicate interpretation. Patients with immune suppression, chronic skin disease, or a history of severe drug reactions require a broader differential diagnosis. Recent antibiotic use, anticonvulsant therapy, or other high-risk medications raises concern for a drug-related reaction. Recurrent episodes also influence evaluation, because repeated eruptions following herpes flares can point to a predictable immune response rather than a random rash.
Timing is another critical factor. The interval between a suspected trigger and the appearance of the rash helps determine whether the trigger is plausible. Clinicians look for patterns of recurrence, improvement, and previous diagnoses. If a patient has had similar lesions before, especially after cold sores, that history may strongly support erythema multiforme even before tests are completed.
Conclusion
Erythema multiforme is diagnosed through a combination of pattern recognition, careful history taking, physical examination, and targeted testing when needed. The characteristic target lesions, acral distribution, fixed lesion behavior, and possible mucosal involvement are the most important clues. A search for triggers such as herpes simplex infection, respiratory infection, or medication exposure helps explain why the immune reaction developed. When the presentation is atypical or severe, blood tests and skin biopsy can clarify the diagnosis and exclude conditions with similar features. In practice, accurate diagnosis depends on integrating clinical appearance with pathology and trigger assessment, allowing clinicians to distinguish erythema multiforme from more serious blistering or drug-related disorders and to guide appropriate management.